Cargando…
Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells
Reduced SIRT2 deacetylation and increased p300 acetylation activity leads to a concerted mechanism of hyperacetylation at specific histone lysine sites (H3K9, H3K14, and H3K18) in castration-resistant prostate cancer (CRPC). We examined whether circulating tumor cells (CTCs) identify patients with a...
Autores principales: | Filon, Mikolaj, Yang, Bing, Purohit, Tanaya A., Schehr, Jennifer, Singh, Anupama, Bigarella, Marcelo, Lewis, Peter, Denu, John, Lang, Joshua, Jarrard, David F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360924/ https://www.ncbi.nlm.nih.gov/pubmed/37477521 http://dx.doi.org/10.18632/oncotarget.28477 |
Ejemplares similares
-
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022) -
Protein Lysine Acetylation
by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015) -
Curcumin, COX-2, and Protein p300/CBP
por: Jung, Ki Tae, et al.
Publicado: (2014) -
Dimeric structure of p300/CBP associated factor
por: Shi, Shasha, et al.
Publicado: (2014) -
Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016)